← Back to Search

Trabecular Micro-Bypass System

Implant Group for Glaucoma

N/A
Waitlist Available
Research Sponsored by Glaukos Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12 postoperative
Awards & highlights

Study Summary

Prospective, multi-center, single-arm clinical trial to evaluate the safety and effectiveness of the Glaukos® Trabecular Micro-Bypass System Model iS3 (three stents per study eye) in subjects with refractory glaucoma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12 postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary effectiveness endpoint

Trial Design

1Treatment groups
Experimental Treatment
Group I: Implant GroupExperimental Treatment1 Intervention
Qualified eyes with refractory glaucoma will be implanted unilaterally with the Glaukos® Trabecular Micro-Bypass System Model iS3 (three G2-W stents per study eye), and will be followed through 12 months postoperative.

Find a Location

Who is running the clinical trial?

Glaukos CorporationLead Sponsor
65 Previous Clinical Trials
8,975 Total Patients Enrolled
35 Trials studying Glaucoma
4,909 Patients Enrolled for Glaucoma
Kerry Stephens, O.D.Study ChairGlaukos Corporation
4 Previous Clinical Trials
1,754 Total Patients Enrolled
2 Trials studying Glaucoma
1,010 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma
2018. "Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03639870.
All > Glaucoma
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top